The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hyperandrogenism


Psychiatry related information on Hyperandrogenism


High impact information on Hyperandrogenism


Chemical compound and disease context of Hyperandrogenism


Biological context of Hyperandrogenism


Anatomical context of Hyperandrogenism


Gene context of Hyperandrogenism


Analytical, diagnostic and therapeutic context of Hyperandrogenism


  1. Obesity and endocrine disorders in women taking valproate for epilepsy. Isojärvi, J.I., Laatikainen, T.J., Knip, M., Pakarinen, A.J., Juntunen, K.T., Myllylä, V.V. Ann. Neurol. (1996) [Pubmed]
  2. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study. Morin-Papunen, L., Vauhkonen, I., Koivunen, R., Ruokonen, A., Martikainen, H., Tapanainen, J.S. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  3. Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. Ibáñez, L., Ong, K.K., Mongan, N., Jääskeläinen, J., Marcos, M.V., Hughes, I.A., De Zegher, F., Dunger, D.B. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  4. Children with classic congenital adrenal hyperplasia have decreased amygdala volume: potential prenatal and postnatal hormonal effects. Merke, D.P., Fields, J.D., Keil, M.F., Vaituzis, A.C., Chrousos, G.P., Giedd, J.N. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  5. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. Gill, S., Taylor, A.E., Martin, K.A., Welt, C.K., Adams, J.M., Hall, J.E. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  6. The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence. Rasgon, N. Journal of clinical psychopharmacology. (2004) [Pubmed]
  7. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. Nestler, J.E., Jakubowicz, D.J. N. Engl. J. Med. (1996) [Pubmed]
  8. Hyperandrogenism in polycystic ovary syndrome. Stewart, P.M., Edwards, C.R. N. Engl. J. Med. (1994) [Pubmed]
  9. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. Isojärvi, J.I., Laatikainen, T.J., Pakarinen, A.J., Juntunen, K.T., Myllylä, V.V. N. Engl. J. Med. (1993) [Pubmed]
  10. Detection of functional ovarian hyperandrogenism in women with androgen excess. Ehrmann, D.A., Rosenfield, R.L., Barnes, R.B., Brigell, D.F., Sheikh, Z. N. Engl. J. Med. (1992) [Pubmed]
  11. Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. Hogeveen, K.N., Cousin, P., Pugeat, M., Dewailly, D., Soudan, B., Hammond, G.L. J. Clin. Invest. (2002) [Pubmed]
  12. Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Zhang, L.H., Rodriguez, H., Ohno, S., Miller, W.L. Proc. Natl. Acad. Sci. U.S.A. (1995) [Pubmed]
  13. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Gharani, N., Waterworth, D.M., Batty, S., White, D., Gilling-Smith, C., Conway, G.S., McCarthy, M., Franks, S., Williamson, R. Hum. Mol. Genet. (1997) [Pubmed]
  14. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Vainionpää, L.K., Rättyä, J., Knip, M., Tapanainen, J.S., Pakarinen, A.J., Lanning, P., Tekay, A., Myllylä, V.V., Isojärvi, J.I. Ann. Neurol. (1999) [Pubmed]
  15. Polycystic ovaries in Hirsute women with normal menses. Carmina, E., Lobo, R.A. Am. J. Med. (2001) [Pubmed]
  16. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Dunaif, A. Endocr. Rev. (1997) [Pubmed]
  17. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Urbanek, M., Legro, R.S., Driscoll, D.A., Azziz, R., Ehrmann, D.A., Norman, R.J., Strauss, J.F., Spielman, R.S., Dunaif, A. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  18. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism. Ibáñez, L., Valls, C., Ferrer, A., Marcos, M.V., Rodriguez-Hierro, F., de Zegher, F. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  19. The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche. Vuguin, P., Linder, B., Rosenfeld, R.G., Saenger, P., DiMartino-Nardi, J. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  20. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy. Ibáñez, L., de Zegher, F. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  21. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. Charmandari, E., Weise, M., Bornstein, S.R., Eisenhofer, G., Keil, M.F., Chrousos, G.P., Merke, D.P. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  22. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. Knochenhauer, E.S., Key, T.J., Kahsar-Miller, M., Waggoner, W., Boots, L.R., Azziz, R. J. Clin. Endocrinol. Metab. (1998) [Pubmed]
  23. Ovarian theca cell. Magoffin, D.A. Int. J. Biochem. Cell Biol. (2005) [Pubmed]
  24. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception. Ibáñez, L., Jaramillo, A.M., Ferrer, A., de Zegher, F. Hum. Reprod. (2005) [Pubmed]
  25. Effects of chronic hyperandrogenism and/or administered central nervous system insulin on ovarian manifestation and gonadotropin and steroid secretion. Allon, M.A., Leach, R.E., Dunbar, J., Diamond, M.P. Fertil. Steril. (2005) [Pubmed]
  26. Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism. Peral, B., San Millán, J.L., Castello, R., Moghetti, P., Escobar-Morreale, H.F. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  27. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Panidis, D., Balaris, C., Farmakiotis, D., Rousso, D., Kourtis, A., Balaris, V., Katsikis, I., Zournatzi, V., Diamanti-Kandarakis, E. Clin. Chem. (2005) [Pubmed]
  28. Abnormalities in the serum insulin-like growth factor-1 axis in women with hyperandrogenism. Escobar-Morreale, H.F., Serrano-Gotarredona, J., García-Robles, R., Varela, C., Sancho, J.M. Fertil. Steril. (1998) [Pubmed]
  29. Mutational analysis of the melanocortin-4 receptor (MC4R) gene in children with premature pubarche and adolescent girls with hyperandrogenism. Roldan Martin, M.B., White, C., Kammerer, C., Witchel, S.F. Fertil. Steril. (2004) [Pubmed]
  30. Frequency of the T228A polymorphism in the SORBS1 gene in children with premature pubarche and in adolescent girls with hyperandrogenism. Witchel, S.F., Trivedi, R.N., Kammerer, C. Fertil. Steril. (2003) [Pubmed]
  31. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. Kaltsas, G.A., Isidori, A.M., Kola, B.P., Skelly, R.H., Chew, S.L., Jenkins, P.J., Monson, J.P., Grossman, A.B., Besser, G.M. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  32. Scintigraphic localization of ovarian dysfunction. Mountz, J.M., Gross, M.D., Shapiro, B., Barkan, A.L., Woodbury, M.C., Schteingart, D.E., Ayers, J.W. J. Nucl. Med. (1988) [Pubmed]
  33. Immunoradiometric assay of human intact proinsulin applied to patients with type 2 diabetes, impaired glucose tolerance, and hyperandrogenism. Chevenne, D., Ruiz, J., Lohmann, L., Laudat, A., Leblanc, H., Gray, I.P., Passa, P., Porquet, D. Clin. Chem. (1994) [Pubmed]
  34. Polycystic ovary syndrome. Taylor, A.E. Endocrinol. Metab. Clin. North Am. (1998) [Pubmed]
  35. Changes in sex hormones during an oral glucose tolerance test in healthy premenopausal women. Ivandić, A., Prpić-Krizevac, I., Jakić, M., Bacun, T. Fertil. Steril. (1999) [Pubmed]
WikiGenes - Universities